SCHEMBL8749783

SCHEMBL8749783

C=Cc1ccc(CSc2ccccc2C(=O)OC2CC(=O)NC2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 4/20 0.41
KDM4E B2RXH2 1/20 0.36
PTPRG P23470 2/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
LMNA P02545 4/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 2/20 0.34
PSD A5PKW4 1/20 0.33
DDB1 Q16531 3/20 0.33
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SLC12A2 P55011 1/20 0.32
SLC12A5 Q9H2X9 1/20 0.32
POLB P06746 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3813541 0.75 CRBN (0.33) CRBNMAPT
SCHEMBL8749795 0.74 KMT2A (0.40) CRBNKDM4EPTPRGKMT2AMEN1
SCHEMBL8433852 0.73 PTPRG (0.58) KDM4EPTPRGKMT2AMEN1LMNA
SCHEMBL8749837 0.72 CYP2C19 (0.32) SMN1; SMN2POLBALDH1A1
SCHEMBL1068302 0.66 GAA (0.48) CRBNKMT2AMEN1LMNADDB1
Ammonia Solution, Strong SCHEMBL9774304 0.65 GAA (0.47) CRBNKMT2AMEN1LMNADDB1
SCHEMBL1887461 0.65 TLR9 (0.45) CRBNKDM4EKMT2AMEN1MAPT
SCHEMBL28411469 0.62 GLA (0.56) CRBNKMT2ALMNAMAPTHTT
SCHEMBL309593 0.61 MAP3K14 (0.35) CRBNKMT2AMEN1L3MBTL1DDB1
SCHEMBL30363164 0.61 ALDH1A1 (0.39) KDM4ELMNAMAPTPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0496473-B1 Method of preparing biologically active reagents from succinimide-containing polymers, analytical element and methods of use JOHNSON & JOHNSON CLIN DIAG (US) 1997-03-26 EP claimed
EP-0496472-B1 Succinimide containing polymers and latices prepared from same JOHNSON & JOHNSON CLIN DIAG (US) 1995-11-29 EP claimed
US-5308749-A REACTING A WATER INSOLUBLE, NONPOROUS PARTICLE OF A NONCROSSLINKED COPOLYMER WITH A BIOLOGICALLY ACTIVE SUBSTANCE EASTMAN KODAK COMPANY (US) 1994-05-03 US claimed
US-5200462-A Water-insoluble, noncrosslinked, nonporous; diagnostic assays EASTMAN KODAK COMPANY (US) 1993-04-06 US claimed
EP-0496472-A1 Succinimide containing polymers and latices prepared from same Johnson & Johnson Clinical Diagnostics, Inc. (US) 1992-07-29 EP claimed
EP-0496473-A2 Method of preparing biologically active reagents from succinimide-containing polymers, analytical element and methods of use Johnson & Johnson Clinical Diagnostics, Inc. (US) 1992-07-29 EP claimed
EP-0496473-B1 Method of preparing biologically active reagents from succinimide-containing polymers, analytical element and methods of use JOHNSON & JOHNSON CLIN DIAG (US) 1997-03-26 EP disclosed
EP-0496472-B1 Succinimide containing polymers and latices prepared from same JOHNSON & JOHNSON CLIN DIAG (US) 1995-11-29 EP disclosed
US-5308749-A REACTING A WATER INSOLUBLE, NONPOROUS PARTICLE OF A NONCROSSLINKED COPOLYMER WITH A BIOLOGICALLY ACTIVE SUBSTANCE EASTMAN KODAK COMPANY (US) 1994-05-03 US disclosed
US-5200462-A Water-insoluble, noncrosslinked, nonporous; diagnostic assays EASTMAN KODAK COMPANY (US) 1993-04-06 US disclosed
EP-0496472-A1 Succinimide containing polymers and latices prepared from same Johnson & Johnson Clinical Diagnostics, Inc. (US) 1992-07-29 EP disclosed
EP-0496473-A2 Method of preparing biologically active reagents from succinimide-containing polymers, analytical element and methods of use Johnson & Johnson Clinical Diagnostics, Inc. (US) 1992-07-29 EP disclosed